{"status":"success","data":{"title":"Cystitis and Pyelonephritis in Women","slug":"cystitis-pregnant","tags":["Nitrofurantoin","sulfamethoxazole","fosfomycin","pivmecillinam","ofloxacin","ciprofloxacin","levofloxacin","amoxicillin-clavulanate","cefdinir","cefaclor","cefpodoxime-proxetil","Trimethoprim-sulfamethoxazole"],"collection":["infectious disease","genitourinary"],"content":"\n\n\n# Cystitis and Pyelonephritis in Women\n\n**2010 IDSA and ESMID guidelines on antibiotic selection**\n\nTarget population = Acute, uncomplicated cystitis and pyelonephritis in women \n\n-   Premenopausal, non-pregnant women without known urological abnormalities or co-morbidities (i.e. DM)\n\n## Acute uncomplicated cystitis\n\n**<span class=\"drug\">Nitrofurantoin</span>** (100 mg PO BID x 5 days)\n**<span class=\"drug\">Trimethoprim</span>-sulfamethoxazole** (1 DS tab PO BID x 3 days)\n1.  Rising resistance rates \n2.  Only give if local antibiogram shows &lt; 20% resistance\n\n**<span class=\"drug\">Fosfomycin</span>** (3 gm PO x 1) \n1.  Slightly less efficiacy compared to standard short-course regimens \n\n**<span class=\"drug\">Pivmecillinam</span>** (400 mg PO BID x 3-7 days) \n1.  Only available in Europe\n\n**<span class=\"drug\">Fluoroquinolones</span>** (3-day course of ofloxacin, ciprofloxacin, or levofloxacin) \n1.  Avoid if possible to minimize selection of drug-resistant organisms\n\n**Beta-lactams** (3-7 day course of <span class=\"drug\">amoxicillin</span>-clavulanate, <span class=\"drug\">cefdinir</span>, <span class=\"drug\">cefaclor</span>, <span class=\"drug\">cefpodoxime</span>-proxetil) \n1.  Avoid if possible to minimize selection of drug-resistant organisms\n2.   Inferior efficacy compared with standard regimens\n3.  <span class=\"drug\">Cephalexin</span> less well studied\n\n## Acute Pyelonephritis\n\n**Urine analysis** and **urine culture** should always be performed \n\n**<span class=\"drug\">Ciprofloxacin</span>** (500 mg po BID x 7 days) +/- **<span class=\"drug\">ciprofloxacin</span>** 400 mg IV x 1 dose\nIf **&gt; 10% resistance to fluoroquinolones**, give 1-time IV dose:\n-   <span class=\"drug\">Ceftriaxone</span> 1 gm IV, or \n-   An aminoglycoside  \n\nIf **&lt; 10% resistance rate,** alternative oral fluoroquinolone outpatient dosing options: \n-   <span class=\"drug\">Ciprofloxacin</span> XR 1000 mg po daily x 7 days, or\n-   <span class=\"drug\">Levofloxacin</span> 750 mg po daily x 5 days \n\n**<span class=\"drug\">Trimethoprim</span>-sulfamethoxazole** (1 tab DS PO BID x 14 days) \n1.  If resistance rate unknown, give 1-time dose of <span class=\"drug\">ceftriaxone</span> 1 gm IV or  aminoglycoside first\n\n**  Beta-lactams** (10-14 day course) \n1.  Because of less efficacy, give 1-time dose of <span class=\"drug\">ceftriaxone</span> 1 gm IV or aminoglycoside first \n\n## References\n\n-   [Gupta K et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the IDSA and the ESMID. Clin Infect Dis. 2011; 52(5).](https://www.ncbi.nlm.nih.gov/pubmed/10589881)\n"}}